3-(3-Oxo-2,3-dihydro-4H-benzo[b][1,4]oxazin-4-yl)propanenitrile, 97%, 25g

METHYL 3-(METHOXYCARBONYL)-1-METHYL-1H-PYRROLE-2-ACETATE, 95.0%, 10g

Methyl 3-hydroxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate, 95%, 5g

Glass syringe with Luer Lock connection (glass, metal), 50 ml, 1 piece

(5-Aminobenzo[d]isoxazol-3-yl)carbamic acid tert-butyl ester, 95.0%, 100mg

Ruthenium(III) chloride, pure, anhydrous, 1 g, glass packaging

(E)-3-(4-Bromophenyl)acrylaldehyde, 95%, 5g

4,5-Dimethyl-thiazol-2-ylamine, 95.0%, 5g

ETHYL 2-(2-CYANOETHYLAMINO)ACETATE, 95.0%, 250mg

Canertinib, 98%, 1g

4,5-Dibromo-1H-imidazole, 95.0%, 500mg

3-(Hydroxymethyl)oxetan-3-ol, 95.0%, 100mg

4-Phenylazobenzoyl Chloride>98.0%(GC)(T)1g